1soh
From Proteopedia
(Difference between revisions)
m (Protected "1soh" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1soh.png|left|200px]] | ||
| - | |||
{{STRUCTURE_1soh| PDB=1soh | SCENE= }} | {{STRUCTURE_1soh| PDB=1soh | SCENE= }} | ||
| - | |||
===The structure of human apolipoprotein C-II in dodecyl phosphocholine=== | ===The structure of human apolipoprotein C-II in dodecyl phosphocholine=== | ||
| + | {{ABSTRACT_PUBMED_15209504}} | ||
| - | + | ==Disease== | |
| + | [[http://www.uniprot.org/uniprot/APOC2_HUMAN APOC2_HUMAN]] Defects in APOC2 are the cause of hyperlipoproteinemia type 1B (HLPP1B) [MIM:[http://omim.org/entry/207750 207750]]. It is an autosomal recessive trait characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis.<ref>PMID:8323539</ref> | ||
| + | |||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/APOC2_HUMAN APOC2_HUMAN]] Component of the very low density lipoprotein (VLDL) fraction in plasma, and is an activator of several triacylglycerol lipases. The association of APOC2 with plasma chylomicrons, VLDL, and HDL is reversible, a function of the secretion and catabolism of triglyceride-rich lipoproteins, and changes rapidly. | ||
==About this Structure== | ==About this Structure== | ||
| Line 11: | Line 13: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:015209504</ref><references group="xtra"/> | + | <ref group="xtra">PMID:015209504</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Gooley, P R.]] | [[Category: Gooley, P R.]] | ||
Revision as of 02:19, 25 March 2013
Contents |
The structure of human apolipoprotein C-II in dodecyl phosphocholine
Template:ABSTRACT PUBMED 15209504
Disease
[APOC2_HUMAN] Defects in APOC2 are the cause of hyperlipoproteinemia type 1B (HLPP1B) [MIM:207750]. It is an autosomal recessive trait characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis.[1]
Function
[APOC2_HUMAN] Component of the very low density lipoprotein (VLDL) fraction in plasma, and is an activator of several triacylglycerol lipases. The association of APOC2 with plasma chylomicrons, VLDL, and HDL is reversible, a function of the secretion and catabolism of triglyceride-rich lipoproteins, and changes rapidly.
About this Structure
1soh is a 1 chain structure with sequence from Homo sapiens. Full experimental information is available from OCA.
Reference
- MacRaild CA, Howlett GJ, Gooley PR. The structure and interactions of human apolipoprotein C-II in dodecyl phosphocholine. Biochemistry. 2004 Jun 29;43(25):8084-93. PMID:15209504 doi:10.1021/bi049817l
- ↑ Inadera H, Hibino A, Kobayashi J, Kanzaki T, Shirai K, Yukawa S, Saito Y, Yoshida S. A missense mutation (Trp 26-->Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama). Biochem Biophys Res Commun. 1993 Jun 30;193(3):1174-83. PMID:8323539 doi:http://dx.doi.org/S0006-291X(83)71749-3
